Sonoma Pharmaceuticals Inc (SNOA)

Panoramica Notizia Cronologia dei prezzi Financials Perché SNOA Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Sonoma Pharmaceuticals Inc

Healthcare (1200)

800-759-9305

5445 CONESTOGA COURT, SUITE 150, BOULDER, CA

Prossima data di guadagno

Ultimi documenti SEC

SNOA's Discussions on Twitter

Confronta SNOA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SNOA Sonoma Pharmaceuticals Inc	2.79	3.84M	12.31M	-5.08M	-5.20M	-1.52
ZTS Zoetis Inc	176.74	80.59B	9.15B	2.43B	2.31B	4.92
HLN Haleon Plc Adr	9.72	44.17B	14.26B	1.55B	0	0.3327
TAK Takeda Pharmaceutical Co Adr	13.57	42.61B	30.27B	1.93B	3.45B	0.444
TEVA Teva Pharmaceutical Industries Ltd Adr	16.57	18.77B	16.77B	-959.00M	1.37B	-2.00
VTRS Viatris Inc	13.22	15.73B	15.05B	-883.30M	1.89B	1.53

Sonoma Pharmaceuticals Inc Borsa (SNOA) Ultime notizie

Sonoma Pharmaceuticals Inc Azioni (SNOA) Dati Finanziari

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Confronta SNOA con altri titoli

Sonoma Pharmaceuticals Inc Borsa (SNOA) Ultime notizie

Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock - Yahoo Finance

Sonoma Pharmaceuticals (STU:O8Z) Growth Rank : 2 (As of Nov. 26, 2024) - GuruFocus.com

Eye Care Product Lines - Trend Hunter

Alkermes (ALKS) Stock Surges Over 5% Amid Strong Financial Perfo - GuruFocus.com

Sonoma Pharmaceuticals, Inc. Receives New FDA 510(K) Clearance for Microcyn(R)-Based Wound Care Hydrogel - Marketscreener.com

Scar Treatment Market Detailed In New Research Report 2024 | - openPR

Sonoma Pharmaceuticals ends agreement with EMC Pharma - Investing.com

Merck (MRK) Stock Surges Amid Industry Layoff Trends - GuruFocus.com

Sonoma Pharmaceuticals ends agreement with EMC Pharma By Investing.com - Investing.com Australia

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in - PharmiWeb.com

Amarin (AMRN) Stock Surges Amid Mixed Industry Performance - GuruFocus.com

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - AccessWire

Sonoma Pharmaceuticals, Inc. Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - Marketscreener.com

Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.86% - MSN

Animal Wound Care Market to Exhibit a Remarkable CAGR of 7.9% - openPR

AMGN Stock Drops 5% Amid Industry Decline and Earnings Report - GuruFocus.com

Siga Technologies (SIGA) Sees Significant Stock Decline Amidst P - GuruFocus.com

Sonoma Pharmaceuticals gains FDA clearance for hydrogel By Investing.com - Investing.com Australia

Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

Sonoma Pharmaceuticals gains FDA clearance for hydrogel - Investing.com India

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - AccessWire

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Sonoma Pharmaceuticals Inc. (SNOA) Quarterly 10-Q Report - Quartz

Sonoma Pharmaceuticals Inc (SNOA) Quarterly 10-Q Report - Quartzy

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - AccessWire

Certain Options of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Certain Restricted Stock Units of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Certain Warrants of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Certain Preferred stock of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - AccessWire

Sonoma Pharmaceuticals, Inc. to Exhibit At MEDICA 2024 in Dusseldorf - Marketscreener.com

Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com

Unveiling the Future: Animal Wound Care Market to USD 1.24 BILLION IN 2023, Forecast by 2030, Featuring a C... - WhaTech

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - AccessWire

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - AccessWire

Scar Treatment Market to See Booming Growth 2024-2031 | Bausch - openPR

Keloid Treatment Market Latest Report 2023-2031 - InsightAce Analytic

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Recent Developments in the Eye Skin Care Market - openPR

Keloid Treatment Market: Insights Predicting a $4.72 Billion Valuation by 2031 - WhaTech

Hypertrophic Scar Treatment Market Growth, Trends, and Industry Share Analysis (2024-2032) - News in Assen

Sonoma Pharmaceuticals (SNOA) Shares Surge Amid Positive Market Activity - GuruFocus.com

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Williams-Sonoma, Inc. (WSM) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Sonoma Pharmaceuticals Inc Azioni (SNOA) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SNOA